Article Type

1 - 15 of 120 Results       Clear All

In Conversation with Dr. Deepak Srivastava, President of Gladstone Institutes

Gladstone in the News March 3, 2025

In Conversation with Dr. Deepak Srivastava, President of Gladstone Institutes

The San Francisco Experience—In a podcast interview, Gladstone President Deepak Srivastava discusses the mission of Gladstone Institutes, and describes how advances in stem cell biology, genome engineering, and artificial intelligence are making it possible to understand the core of diseases and develop new cures.

Gladstone Experts Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCs

Nobel Winner Shinya Yamanaka: Cell Therapy Is ‘Very Promising’ For Cancer, Parkinson’s, More

Gladstone in the News October 9, 2024

Nobel Winner Shinya Yamanaka: Cell Therapy Is ‘Very Promising’ For Cancer, Parkinson’s, More

Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.

Gladstone Experts Yamanaka Lab Stem Cells/iPSCs

Podcast: ’The Voice Weekly’ Featuring Deepak Srivastava

Gladstone in the News June 12, 2024

Podcast: ’The Voice Weekly’ Featuring Deepak Srivastava

The Voice of San Francisco—Gladstone President Deepak Srivastava, MD, talks about technologies driving the next wave of medicine, the importance of philanthropy dollars in fueling scientific breakthroughs, and how biotech is still breathing life into San Francisco’s Mission Bay neighborhood.

Srivastava Lab Aging AI CRISPR/Gene Editing Stem Cells/iPSCs

Gladstone to Expand Stem Cell Research Capabilities with Multi-Million Dollar Regenerative Medicine Grant

Sam Hu prepares induced pluripotent stem cells.
Article March 11, 2024

Gladstone to Expand Stem Cell Research Capabilities with Multi-Million Dollar Regenerative Medicine Grant

Funds from the California Institute for Regenerative Medicine will allow Gladstone to bolster its disease-modeling technologies, add robust CRISPR screening capabilities, and educate young researchers on the latest in stem cell science.

Grants CRISPR/Gene Editing Disease Models Organoids Regenerative Medicine Stem Cells/iPSCs

Heart-to-Heart Connection: Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life

Exploratorium hero image
Article February 8, 2024

Heart-to-Heart Connection: Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life

At San Francisco’s Exploratorium, visitors sync their heartbeat with living heart cells; the first-of-its-kind exhibit was created through the museum’s long-running partnership with scientists at Gladstone Institutes.

News Release Stem Cells/iPSCs Conklin Lab Yamanaka Lab Cardiovascular Disease Research (Publication)

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

Gladstone in the News November 7, 2023

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs

CRISPR Cures for Cancer: Partnership to Accelerate Cell Therapy Using Genomics

Gladstone in the News September 18, 2023

CRISPR Cures for Cancer: Partnership to Accelerate Cell Therapy Using Genomics

UCSF News—Gladstone Senior Investigators Alex Marson and Jennifer Doudna, and President of the UC San Francisco Helen Diller Family Comprehensive Cancer Center Alan Ashworth, will head the newly launched CRISPR Cures for Cancer Initiative, which will fund research at the intersection of genomic technologies and cellular immunotherapies at Gladstone Institutes, UC San Francisco, and the Innovative Genomics Institute at UC Berkeley.

Gladstone Experts Cancer Data Science and Biotechnology Genomic Immunology Doudna Lab Marson Lab CRISPR/Gene Editing Stem Cells/iPSCs

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media